Consonance Capital Management as of Dec. 31, 2019
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 35 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals (AUPH) | 8.2 | $134M | 6.6M | 20.26 | |
| ArQule | 8.2 | $134M | 6.7M | 19.96 | |
| Karyopharm Therapeutics (KPTI) | 7.2 | $118M | 6.1M | 19.17 | |
| Epizyme | 6.5 | $106M | 4.3M | 24.60 | |
| United Therapeutics Corporation (UTHR) | 4.9 | $81M | 919k | 88.08 | |
| Chemocentryx | 4.6 | $75M | 1.9M | 39.55 | |
| Align Technology (ALGN) | 4.6 | $75M | 269k | 279.04 | |
| Kadmon Hldgs | 4.3 | $71M | 16M | 4.53 | |
| Intra Cellular Therapies (ITCI) | 4.1 | $68M | 2.0M | 34.31 | |
| Uniqure Nv (QURE) | 4.1 | $67M | 929k | 71.66 | |
| Gw Pharmaceuticals Plc ads | 3.9 | $63M | 605k | 104.56 | |
| EXACT Sciences Corporation (EXAS) | 3.3 | $54M | 580k | 92.48 | |
| Axogen (AXGN) | 3.3 | $53M | 3.0M | 17.89 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $46M | 356k | 129.04 | |
| Caredx (CDNA) | 2.8 | $46M | 2.1M | 21.57 | |
| Omeros Corporation (OMER) | 2.8 | $45M | 3.2M | 14.09 | |
| Iovance Biotherapeutics (IOVA) | 2.5 | $42M | 1.5M | 27.68 | |
| Oxford Immunotec Global | 2.4 | $39M | 2.4M | 16.60 | |
| Assembly Biosciences | 2.4 | $38M | 1.9M | 20.46 | |
| Retrophin | 2.0 | $33M | 2.3M | 14.20 | |
| Tandem Diabetes Care (TNDM) | 2.0 | $33M | 551k | 59.61 | |
| Iveric Bio | 1.8 | $29M | 3.4M | 8.58 | |
| Liminal Biosciences | 1.7 | $28M | 3.3M | 8.38 | |
| Vericel (VCEL) | 1.6 | $27M | 1.6M | 17.40 | |
| Aptose Biosciences | 1.6 | $27M | 4.8M | 5.67 | |
| Insulet Corporation (PODD) | 1.6 | $27M | 156k | 171.20 | |
| Adma Biologics (ADMA) | 1.3 | $21M | 5.2M | 4.00 | |
| STAAR Surgical Company (STAA) | 0.9 | $15M | 426k | 35.17 | |
| Ovid Therapeutics (OVID) | 0.7 | $12M | 2.9M | 4.15 | |
| Krystal Biotech (KRYS) | 0.7 | $11M | 204k | 55.38 | |
| Biotelemetry | 0.4 | $7.2M | 155k | 46.30 | |
| Amicus Therapeutics (FOLD) | 0.3 | $4.9M | 508k | 9.74 | |
| Turning Point Therapeutics I | 0.3 | $4.4M | 71k | 62.29 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $4.1M | 135k | 30.62 | |
| Morphosys (MOR) | 0.1 | $769k | 22k | 35.67 |
